ReNew posts ₹377 crore net profit in September quarter-March 2024-www.financetom.com

ReNew posts ₹377 crore net profit in September quarter

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

ReNew posts ₹377 crore net profit in September quarter

Nov 20, 2023 1:41 PM

Clean energy player ReNew on Monday reported a net profit of ₹377.1 crore during the September 2023 quarter, supported by higher income.

It had clocked a ₹98.6 crore net loss during the July-September period of the last fiscal, the company said in a statement.

Its total income rose to Rs 2,863.2 crore from Rs 2,240.9 crore in the year-ago quarter. The adjusted EBITDA was Rs 2,129.8 crore against Rs 1,820.9 crore in Q2 FY23.

As of September 30, 2023, the company said, its portfolio stood at 13.8 GW, including solar and wind capacities, compared to 13.4 GW a year ago.

Previous page： Next page： Illinois Tool Works forecasts 2025 profit below estimates

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Feb 5, 2025

...

Illinois Tool Works forecasts 2025 profit below estimates

Feb 5, 2025

Feb 5 (Reuters) - Illinois Tool Works ( ITW ) on Wednesday forecast annual profit below Wall Street expectations, as high borrowing rates and sticky inflation force customers to slow investments on industrial equipment. Shares of the company were down 3% before the bell. Higher borrowing costs have reduced corporate spending, muting the impact of steady demand from the automotive...

EyePoint's Phase 2 Trial of Duravyu to Treat Diabetic Macular Edema Meets Endpoints; Shares Still Slump Pre-Bell

Feb 5, 2025

09:12 AM EST, 02/05/2025 (MT Newswires) -- EyePoint Pharmaceuticals ( EYPT ) reported six-month results from a phase 2 trial of Duravyu to treat diabetic macular edema that met primary and secondary endpoints, but its shares still slumped in premarket trading. The company said the trial demonstrated clinically meaningful outcomes, such as continued safety with no Duravyu-related ocular or systemic...

Equinor Unveils $5 Billion Buyback, Trims Renewables Spending As Oil & Gas Output Rises

Feb 5, 2025

Equinor ASA ( EQNR ) shares are trading lower after the company reported fourth-quarter FY24 results. Revenue and other income fell 5% year-over-year (Y/Y) to $27.654 billion and adjusted revenue declined 7% Y/Y to $26.418 billion. The consensus estimate stood at $25.973 billion. Total equity liquids and gas production decreased 6% Y/Y to 2,072 mboe per day, with equity liquids production falling 6% Y/Y to 1,081 mboe per day...